article Open AccessTop 1% cited

Cutaneous Injury Induces the Release of Cathelicidin Anti-Microbial Peptides Active Against Group A Streptococcus

Journal of Investigative Dermatology · 2001 · Vol. 117(1) · pp. 91–97

Robert A. Dorschner(University of California San Diego)Vasumati K. Pestonjamasp(University of California San Diego)Seema Tamakuwala(University of California San Diego)Takaaki Ohtake(University of California San Diego)Jennifer A. Rudisill(University of California San Diego)Victor Nizet(University of California San Diego)Birgitta Agerberth(Karolinska Institutet)Guðmundur H. GuðmundssonRichard L. Gallo✉(University of California San Diego)

View via DOI Full-text PDF

Antimicrobial Peptides and Activities Biochemical and Structural Characterization Streptococcal Infections and TreatmentsCathelicidinStreptococcusMicrobiologyMedicineChemistryInternal medicineAntimicrobial peptidesBiologyAntimicrobialBacteria

MeSH terms

Amino Acid SequenceAnimalsFemaleHumansMaleMice, Inbred C57BLMolecular Sequence DataProteinsRNA, MessengerSkinStreptococcal InfectionsStreptococcus pyogenesWound HealingKeratinocytesGene Expression

Citations

563

FWCI

11.72

field-weighted impact

References

Percentile

99%

vs. same field & year

Citations per year

Cited by

Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up‐regulated in myeloid cells by 1,25‐dihydroxyvitamin D <sub>3</sub>